ASN-001
Product Specifications
UNSPSC Description
ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has anticancer activity and can be used for research in the field of prostate cancer[1].
Target Antigen
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/asn-001.html
Smiles
FC1=CC=C(C2=NC=C(C(C3=CC=NC=C3)(C)O)S2)C=C1
Molecular Weight
300.35
References & Citations
[1]Barata P, et al. Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy. Prostate. 2018 Sep;78(13):1035-1041.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-164457/ASN-001-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-164457/
Clinical Information
Phase 1
CAS Number
1429329-63-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![SNX12 Mouse Monoclonal Antibody [Clone ID: OTI1B10]](https://cdn.genprice.uk/genprice/genprice4.png)
![Mouse Monoclonal p53 Antibody (rTP53/8993) [Allophycocyanin]](https://cdn.genprice.uk/genprice/genprice3.png)
MBS6351779-01 0.1 mL
STARD5, NT (STARD5, StAR-related lipid transfer protein 5, START domain-containing protein 5) (MaxLight 405)
Ask
View Details MBS6351779-02 5x 0.1 mL
STARD5, NT (STARD5, StAR-related lipid transfer protein 5, START domain-containing protein 5) (MaxLight 405)
Ask
View Details